Creating a free account will enable you to subscribe to our daily and weekly email newsletters, as well as customize your reading experience to show only the categories most relevant to you.
Signing up only take a few minutes, so why not give it a try and see what you've been missing out on.
Last week the European Academy of Allergy and Clinical Immunology (EAACI) conducted three days of diagnostic tests for allergies in the European Parliament. In total 350 people took the opportunity to be examined for sensitivity to the most common allergens and to be given an expert advice, and 47% of them tested positively.
Among the 150 million Europeans affected by allergic diseases, approximately one fifth are affected by severe, debilitating diseases, but these are neglected as a public health concern. Around 50% of allergies sufferers are undiagnosed, and others often have to wait a considerable time before a diagnosis becomes available.
The event was organised with the sponsorship of Claudiu Ciprian Tănăsescu MEP and the tests were conducted by a medical team led by Professor Peter Hellings, Professor at the Catholic University of Leuven and Clinic Head at the Department of Otorhinolaryngology of the University Hospitals Leuven.
Professor Nikos Papadopoulos, the President of EAACI, said: "We knew that allergies are a major health issue but frankly we have been overwhelmed by the interest of people from the European Parliament. It demonstrates the burden of allergy and that it is not sufficiently recognised." Professor Antonella Muraro, Secretary General of EAACI added: "There is a need to acknowledge the increasing demand and to improve allergy services across European countries."
Professor Peter Hellings said: "My team and I conducted diagnostic tests and provided advice non-stop on each of the three days. Some of the participants had quite severe symptoms. A first step towards helping patients with allergy should be to provide them with easier access to diagnosis."
Claudiu Ciprian Tănăsescu MEP said: "I am very happy that together with EAACI we have managed to facilitate an allergy test for a considerable number of people in the European Parliament. This common chronic disease has a serious impact on people's lives, and I urge Member States to develop adequate national allergy programmes."
EAACI therefore urges those MEPs who have not already done so to sign the Written Declaration on Recognising the Burden of Allergic Disease before it closes on 21st January.
Information on the Written Declaration can be found at: http://www.eaaci.org/activities/written-declaration-on-allergies.html
Article adapted by Medical News Today from original press release. Click 'references' tab above for source.
Visit our Allergy category page for the latest news on this subject.
Please use one of the following formats to cite this article in your essay, paper or report:
EAACI. "EAACI calls on MEPs to address allergies diagnosis gap." Medical News Today. MediLexicon, Intl., 14 Jan. 2014. Web.
11 Mar. 2014. <http://www.medicalnewstoday.com/releases/271154>
EAACI. (2014, January 14). "EAACI calls on MEPs to address allergies diagnosis gap." Medical News Today. Retrieved from
Please note: If no author information is provided, the source is cited instead.
If you write about specific medications, operations, or procedures please do not name healthcare professionals by name.
For any corrections of factual information, or to contact our editorial team, please use our feedback form. Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.
This page was printed from: http://www.medicalnewstoday.com/releases/271154.php
Visit www.medicalnewstoday.com for medical news and health news headlines posted throughout the day, every day.
© 2004-2014 All rights reserved. MNT (logo) is the registered trade mark of MediLexicon International Limited.